Round Trip: An Automated Pipeline for Experimental Design, Execution, and Analysis.

Design-Build-Test-Learn automation data analysis high-throughput screening knowledge curation metadata

Journal

ACS synthetic biology
ISSN: 2161-5063
Titre abrégé: ACS Synth Biol
Pays: United States
ID NLM: 101575075

Informations de publication

Date de publication:
18 02 2022
Historique:
pubmed: 1 2 2022
medline: 1 4 2022
entrez: 31 1 2022
Statut: ppublish

Résumé

Synthetic biology is a complex discipline that involves creating detailed, purpose-built designs from genetic parts. This process is often phrased as a Design-Build-Test-Learn loop, where iterative design improvements can be made, implemented, measured, and analyzed. Automation can potentially improve both the end-to-end duration of the process and the utility of data produced by the process. One of the most important considerations for the development of effective automation and quality data is a rigorous description of implicit knowledge encoded as a formal knowledge representation. The development of knowledge representation for the process poses a number of challenges, including developing effective human-machine interfaces, protecting against and repairing user error, providing flexibility for terminological mismatches, and supporting extensibility to new experimental types. We address these challenges with the DARPA SD2 Round Trip software architecture. The Round Trip is an open architecture that automates many of the key steps in the Test and Learn phases of a Design-Build-Test-Learn loop for high-throughput laboratory science. The primary contribution of the Round Trip is to assist with and otherwise automate metadata creation, curation, standardization, and linkage with experimental data. The Round Trip's focus on metadata supports fast, automated, and replicable analysis of experiments as well as experimental situational awareness and experimental interpretability. We highlight the major software components and data representations that enable the Round Trip to speed up the design and analysis of experiments by 2 orders of magnitude over prior

Identifiants

pubmed: 35099189
doi: 10.1021/acssynbio.1c00305
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

608-622

Auteurs

Daniel Bryce (D)

SIFT, LLC., Minneapolis, Minnesota 55401, United States.

Robert P Goldman (RP)

SIFT, LLC., Minneapolis, Minnesota 55401, United States.

Matthew DeHaven (M)

SIFT, LLC., Minneapolis, Minnesota 55401, United States.

Jacob Beal (J)

Raytheon BBN Technologies, Cambridge, Massachusetts 02138, United States.

Bryan Bartley (B)

Raytheon BBN Technologies, Cambridge, Massachusetts 02138, United States.

Tramy T Nguyen (TT)

Raytheon BBN Technologies, Cambridge, Massachusetts 02138, United States.

Nicholas Walczak (N)

Raytheon BBN Technologies, Cambridge, Massachusetts 02138, United States.

Mark Weston (M)

Netrias, Inc., Annapolis, Maryland 21409, United States.

George Zheng (G)

Netrias, Inc., Annapolis, Maryland 21409, United States.

Josh Nowak (J)

Strateos, Inc., Menlo Park, California 94025, United States.

Peter Lee (P)

Ginkgo Bioworks, Inc., Boston, Massachusetts 02210, United States.

Joe Stubbs (J)

Texas Advanced Computing Center, Austin, Texas 78758, United States.

Niall Gaffney (N)

Texas Advanced Computing Center, Austin, Texas 78758, United States.

Matthew W Vaughn (MW)

Texas Advanced Computing Center, Austin, Texas 78758, United States.

Chris John Myers (CJ)

Colorado University, Boulder, Colorado 80203, United States.

Robert C Moseley (RC)

Duke University, Durham, North Carolina 27708, United States.

Steven Haase (S)

Duke University, Durham, North Carolina 27708, United States.

Anastasia Deckard (A)

Geometric Data Analytics, Inc., Durham, North Carolina 27701, United States.

Bree Cummins (B)

Montana State University, Bozeman, Montana 59717, United States.

Nick Leiby (N)

Two Six Technologies, Inc., Arlington, Virginia 22203, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH